Avlar BioVentures Overview

  • Investor Type
  • Venture Capital

  • Status
  • Inactive

  • Investments
  • 34

  • Portfolio
  • 3

  • Exits
  • 20

Exits

Avlar BioVentures General Information

Company Description

Avlar BioVentures was a Cambridge, United Kingdom based venture capital firm. The firm primarily makes early stage and seed investments and targets the biotechnology and healthcare sectors.

Business Details

Website
www.avlar.com
Year Founded
1999
Investor Status
Out of Business
Primary Investor Type
Venture Capital
Corporate Office
  • Highfield Court
  • Madingley
  • Cambridge CB23 8AG
  • England, United Kingdom

Avlar BioVentures Investments (34)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Crescendo Biologics 05-Oct-2012 Later Stage VC Drug Discovery Clinical Trials - Phase 1
TeraView 23-Dec-2011 Electronic Equipment and Instruments Generating Revenue
Amura (Drug Discovery) 31-Jan-2011 Drug Discovery Out of Business
Crescendo Biologics 12-Oct-2009 Drug Discovery Clinical Trials - Phase 1
York Pharma 01-Oct-2008 Distributors (Healthcare) Out of Business
Medical Device Innovations 11-Mar-2008 Therapeutic Devices Out of Business
Medical Device Innovations 01-Mar-2007 Therapeutic Devices Out of Business
CellCentric 18-Jul-2006 Biotechnology Clinical Trials - Phase 1
Paradigm Therapeutics 07-Jul-2006 Later Stage VC Drug Discovery Generating Revenue
Aitua 01-Jun-2006 Joint Venture Private Equity Out of Business
You’re viewing 10 of 34 investments. Get the full list »

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Avlar BioVentures Exits (20)

Company Name Exit Date Exit Type Exit Size
Paion 26-Oct-2023 Bankruptcy: Admin/Reorg
Amura (Drug Discovery) 01-Nov-2017
De Novo Pharmaceuticals 01-Aug-2015
Medical Device Innovations 01-Jun-2014
NXVision 15-Sep-2010
Purely Proteins 16-Jul-2010
Intercytex 30-Jun-2010
Aitua 01-Mar-2010
Velocix 28-Jul-2009 Merger/Acquisition
York Pharma 27-Jul-2009 Bankruptcy: Liquidation
You’re viewing 10 of 20 exits. Get the full list »

Avlar BioVentures Fund Performance

Fund Name Vintage Size Dry Powder DPI RVPI TVPI IRR

This information is available in the PitchBook Platform. To explore Avlar BioVentures‘s full profile, request access.

Request a free trial

Avlar BioVentures Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

Avlar BioVentures FAQs

  • What is Avlar BioVentures?

    Avlar BioVentures was a Cambridge, United Kingdom based venture capital firm.

  • When was Avlar BioVentures founded?

    Avlar BioVentures was founded in 1999.

  • Where is Avlar BioVentures headquartered?

    Avlar BioVentures is headquartered in Cambridge, United Kingdom.

  • How many investments has Avlar BioVentures made?

    Avlar BioVentures has made 34 investments.

  • What has Avlar BioVentures invested in?

    Avlar BioVentures has made numerous investments in companies like Crescendo Biologics, TeraView, and Amura (Drug Discovery) within the Drug Discovery and Electronic Equipment and Instruments industries.

  • What has Avlar BioVentures invested in recently?

    Avlar BioVentures's latest investment was on 05-Oct-2012 in Crescendo Biologics, a company within the Drug Discovery industry.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »